BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32957477)

  • 1.
    Bratek E; Ziembowicz A; Salinska E
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32957477
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment with mGluR2 or mGluR3 Agonists Reduces Apoptosis Induced by Hypoxia-Ischemia in Neonatal Rat Brains.
    Bratek-Gerej E; Bronisz A; Ziembowicz A; Salinska E
    Oxid Med Cell Longev; 2021; 2021():8848015. PubMed ID: 33763176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulatory role of NAAG-mGluR3 signaling on cortical synaptic plasticity after hypoxic ischemia.
    Li K; Lu M; Cui M; Wang X; Zheng Y
    Cell Commun Signal; 2022 Apr; 20(1):55. PubMed ID: 35443669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of group II metabotropic glutamate receptors protects neonatal rat brains from oxidative stress injury after hypoxia-ischemia.
    Bratek E; Ziembowicz A; Bronisz A; Salinska E
    PLoS One; 2018; 13(7):e0200933. PubMed ID: 30044838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group II Metabotropic Glutamate Receptors Reduce Apoptosis and Regulate BDNF and GDNF Levels in Hypoxic-Ischemic Injury in Neonatal Rats.
    Bratek-Gerej E; Ziembowicz A; Salinska E
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
    Cai Z; Lin S; Rhodes PG
    Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
    Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
    Fricker AC; Mok MH; de la Flor R; Shah AJ; Woolley M; Dawson LA; Kew JN
    Neuropharmacology; 2009; 56(6-7):1060-7. PubMed ID: 19285517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
    Lea PM; Wroblewska B; Sarvey JM; Neale JH
    J Neurophysiol; 2001 Mar; 85(3):1097-106. PubMed ID: 11247980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.
    Neale JH; Bzdega T; Wroblewska B
    J Neurochem; 2000 Aug; 75(2):443-52. PubMed ID: 10899918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes.
    Wroblewska B; Santi MR; Neale JH
    Glia; 1998 Oct; 24(2):172-9. PubMed ID: 9728763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylaspartylglutamate and beta-NAAG protect against injury induced by NMDA and hypoxia in primary spinal cord cultures.
    Yourick DL; Koenig ML; Durden AV; Long JB
    Brain Res; 2003 Nov; 991(1-2):56-64. PubMed ID: 14575876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with Group II Metabotropic Glutamate Receptor Agonist LY379268 Protects Neonatal Rat Brains from Oxidative Stress in an Experimental Model of Birth Asphyxia.
    Bratek E; Ziembowicz A; Salinska E
    Brain Sci; 2018 Mar; 8(3):. PubMed ID: 29562588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAAG fails to antagonize synaptic and extrasynaptic NMDA receptors in cerebellar granule neurons.
    Losi G; Vicini S; Neale J
    Neuropharmacology; 2004 Mar; 46(4):490-6. PubMed ID: 14975672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
    Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
    J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.
    Zhong C; Luo Q; Jiang J
    Int J Neurosci; 2014 Dec; 124(12):867-73. PubMed ID: 24494725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.
    Tsai SJ
    Med Sci Monit; 2005 Sep; 11(9):HY39-45. PubMed ID: 16127367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed preconditioning with NMDA receptor antagonists in a rat model of perinatal asphyxia.
    Makarewicz D; Sulejczak D; Duszczyk M; Małek M; Słomka M; Lazarewicz JW
    Folia Neuropathol; 2014; 52(3):270-84. PubMed ID: 25310738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mechanism of the Neuroprotective Effect of Kynurenic Acid in the Experimental Model of Neonatal Hypoxia-Ischemia: The Link to Oxidative Stress.
    Bratek-Gerej E; Ziembowicz A; Godlewski J; Salinska E
    Antioxidants (Basel); 2021 Nov; 10(11):. PubMed ID: 34829646
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.